Sign inJoin waitlistJoin the waitlist

Annie Luetkemeyer

Professor of Clinical Medicine · University of California (San Francisco) School of Medicine

Credentials: · · · ·

History

University of California (San Francisco) School of Medicine
Present

Infectious Disease
University of California-San Francisco
2006–2007
University of California-San Francisco
2004–2006
Internal Medicine
University of California-San Francisco
1999–2002
University of California, San Francisco
Harvard Medical School
1995–1999

Research

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
New England Journal of Medicine · 2021 · 1,404 citations
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
New England Journal of Medicine · 2011 · 435 citations
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
New England Journal of Medicine · 2023 · First of 18 authors · 391 citations

Diane Havlir
20 papers
Connie Celum
18 papers
DW
David Wyles
13 papers
Stephanie Cohen
12 papers
MM
Matthew Makowski
11 papers · 8 as a fellow
Angela Branche
10 papers
Ann Falsey
10 papers
Dahlene Fusco
10 papers
JW
Jennifer Whitaker
10 papers
NR
Nadine Rouphael
10 papers
Paul Goepfert
10 papers
RA
Robert Atmar
10 papers

Grants

The Doxy-PEP Impact Study: A Multi-City US Longitudinal Cohort to Evaluate Doxy-PEP Field Effectiveness, Investigate Associated Antimicrobial Resistance, and Establish Doxy-PEP to Need Ratios
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $4.6M · University of California, San Francisco
2024–2029
Evaluation of Doxycycline Post-Exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-Infected Men Who Have Sex with Men
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $8.3M · University of California, San Francisco
2019–2025

Clinical trials

Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men
Principal investigator · Completed · Phase 4
University of California, San Francisco
2019–2023
A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C
Principal investigator · Withdrawn · Phase 4
University of California, San Francisco
2014–2015
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
Principal investigator · Completed · Phase 4
University of California, San Francisco
2008–2010